E. Norriton, Penn., January 25, 2017 - TGaS® Advisors announced the appointment of two new vice presidents. Tom Goga has been named to lead the benchmarking and advisory services firm's Field Operations, which also includes Incentive Compensation, and Rich Waite will head Commercial Learning & Development.
Goga has extensive experience in large-tier pharmaceutical, biotech and medical device companies and has expertise in a broad range of therapeutic areas. He was vice president of sales at Pernix Therapeutics and of commercial operations at Organogenesis following more than 20 years at Merck & Co., Inc., where his latest position was executive director, commercial operations.
Waite has a broad range of experience in the pharmaceutical, healthcare and consulting industries. He has expertise in learning practice management, leadership development, sales training, learning operations and technology. Most recently vice president, learning and performance solutions, at Delta Point Inc., specializing in customer interaction for life sciences companies, he has also served as Quiet Ambassador at the Quiet Leadership Institute.
About TGaS Advisors
TGaS Advisors is the leading benchmarking and advisory services firm for commercial organizations in the life sciences industry. With a roster of top 50, emerging and precommercial life sciences companies, TGaS provides robust comparative intelligence and collaborative network membership services. The team includes more than 60 experienced professionals, most with senior level experience in the life sciences and related industries.